Delivery Order SPE2DR25D3012-SPE2DR26F4G2Q

<p>The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on February 5, 2026, with a ceiling value of $14,015.65 for Rexulti 1 mg tablets (30-count).</p> <p>Place of performance is Conshohocken, PA. The order has an ultimate completion date of February 6, 2026 and is priced on a firm fixed-price basis. No set-aside was used.</p>

<p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 5, 2026, for REXULTI 0.25 mg tablets (30-count) with a ceiling value of $49,592.87.</p> <p>Place of performance is Conshohocken, PA. The order carries an ultimate completion date of February 6, 2026, and is priced on a firm fixed-price basis with no set-aside.</p>

<p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 5, 2026, with a ceiling value of $2,336.11 for REXULTI 0.25 mg tablets (30-count).</p> <p>Place of performance is Conshohocken, PA. The order is firm fixed price with an ultimate completion date of February 6, 2026. No set-aside was used.</p>

The Defense Logistics Agency awarded a delivery order valued at $5,225.26 to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Rexulti 2 mg tablets (30-count units). This is a firm fixed-price delivery order with no set-aside designation, issued competitively under the company's existing indefinite delivery contract with DLA. The order is scheduled for completion by January 6, 2026, and will be fulfilled from AmerisourceBergen's corporate headquarters location in Conshohocken,...

<p>The Defense Logistics Agency issued a $9,696.79 delivery order to Amerisourcebergen Drug Corp on February 5, 2026, for REXULTI (risperidone) 1 mg tablets, 30-count packages, with a ceiling value of $9,696.79 and ultimate completion date of February 6, 2026.</p> <p>Place of performance is Conshohocken, PA. The order was awarded on a firm fixed-price basis with no set-aside applied.</p>

The Defense Logistics Agency awarded a delivery order valued at $15,446.66 to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Rexulti 1 mg tablets in a 30-count package. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to support federal medical procurement needs. The order is scheduled for completion by September 29, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. This delivery order...

The Defense Logistics Agency awarded a delivery order valued at $1,952.99 to AmerisourceBergen Drug Corp for the supply of Rexulti 2 mg tablets (30-count packaging) on February 4, 2026, with a completion date of February 5, 2026. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, which serves as the company's corporate headquarters and primary distribution center for federal pharmaceutical...

The Defense Logistics Agency awarded a delivery order valued at $7,691.76 to AmerisourceBergen Drug Corp for the supply of Rexulti 1 mg tablets (30-count package). This competitively awarded, firm fixed-price delivery order was issued on December 30, 2025, with an ultimate completion date of December 31, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is...

The Defense Logistics Agency awarded a delivery order valued at $14,851.46 to AmerisourceBergen Drug Corp for the supply of Rexulti 2 mg tablets in a 30-count package. This firm fixed price, competitively awarded contract was issued on June 2, 2025, with an ultimate completion date of June 3, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. As a non-set-aside procurement, this delivery order represents a routine pharmaceutical supply...

The Defense Logistics Agency awarded a $5,259.62 delivery order to Amerisourcebergen Drug Corp (parent company Cencora, Inc.) on February 3, 2026, for the supply of Rexulti 2 mg tablets (30-count) with a completion date of February 4, 2026. This non-set-aside, firm fixed-price delivery order represents a competitively awarded task against a larger contract vehicle and will be performed at the awardee's facility in Conshohocken, Pennsylvania. This delivery order is issued under...